# Sun Pharma announced Monday that it has entered into an agreement to acquire New Jersey-headquartered Organon in an all-cash deal valued at $11.75 billion.

*business · news · 2026-04-27 · ThePrint*

## Key points

- Sun Pharma will acquire Organon for $11.75 billion in an all-cash deal.
- This acquisition will position Sun Pharma among the top 25 pharmaceutical companies globally by revenue.
- The deal marks Sun Pharma’s entry into biosimilars, making it the seventh largest biosimilars player.
- Sun Pharma’s women’s health portfolio will expand, making it one of the top three players in this segment.

**Companies:** Sun Pharma, Organon
**Countries:** India, United States, Brazil, China, Canada, Europe

[Read the full story on ThePrint](https://theprint.in/health/indias-sun-pharma-takes-biosimilar-leap-with-organon-acquisition-in-11-75-billion-all-cash-deal/2915722/)

---

Canonical: https://newsio.io/n/facd7f88-f2f6-4ccb-94fb-12374edac883/sun-pharma-announced-monday-that-it-has-entered-into-an-agreement-to-acquire-new
Summarized by Newsio from ThePrint. https://newsio.io/how-it-works